A natural agonist of RKIP is epigallocatechin gallate (EGCG), which was found to increase RKIP expression in pancreatic adenocarcinoma cells by inhibiting both NF-κB and SNAIL [197]. This evidence concerns the gene PEBP1 and pancreatic adenocarcinoma.